General market risk off sentiment. AVR is holding up well considering. Other biotech firms with no income are selling off at the same time.
Ann: DurAVR Maintains Exceptional Results in New Patient Cohort, page-6
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.75 |
Change
-1.200(6.02%) |
Mkt cap ! $360.4M | |||
| Open | High | Low | Value | Volume |
| $20.00 | $20.00 | $18.75 | $143.6K | 7.561K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 300 | $18.65 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.78 | 518 | 1 |
View Market Depth
| Last trade - 15.58pm 17/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$19.01 |
Change
-1.200 ( 4.85 %) |
||||
| Open | High | Low | Volume | ||
| $19.75 | $19.75 | $19.01 | 464 | ||
| Last updated 11.04am 17/06/2024 ? | |||||
| AVR (ASX) Chart |
